What Estor does

Estor S.p.A. is a privately held Italian medical device company headquartered in Pero (Milan), Italy, that distributes extracorporeal blood purification, organ support, and dialysis devices to hospitals, intensive care units, and nephrology departments. Operating as a B2B distributor, the company acts as the Italian channel for products manufactured by Toray Medical (Japan) and Spectral Medical (Canada), covering six therapeutic areas: sepsis/septic shock, acute kidney injury, chronic kidney disease, acute respiratory failure, mitral valve stenosis, and advanced brain support.

The core portfolio centers on Toraymyxin® (Polymyxin B hemoperfusion for endotoxic septic shock, available in PMX-20R and PMX-05R versions), paired with Spectral Medical's EAA™ Endotoxin Activity Assay, the only FDA-approved and CE-marked rapid diagnostic to guide patient selection. Additional offerings include the HEMOFEEL™ PMMA membrane for continuous renal support, the INTENSA® multimodal extracorporeal organ support system, the EstorFlow® hemoperfusion system, ProLUNG® for low-flow extracorporeal CO2 removal, AURORA cTTM® for selective brain temperature management, the PMMA FILTRYZER dialysis membrane series (B3-A, BG-U, BK-F), TORAYSULFONE and TORAYLIGHT dialyzers, the Inoue® balloon catheter for mitral commissurotomy, and ancillary products (EstorClean Plus® water filtration, EFG Plus® monitoring, RenaCare supplements).

Revenue is generated through hardware/device sales via direct institutional field sales to Italian healthcare institutions; pricing is not publicly disclosed and is set through institutional procurement processes, consistent with Italian medical device regulations (D. Lgs. 46/97, art. 21) restricting promotion to healthcare professionals. Go-to-market is sales-led and supported by clinical education at scientific congresses (SMART Meeting, Vicenza Course, DGIIN/ÖGIAIN, ESICM LIVES, SIAARTI, SIN), medical society partnerships, and dissemination of clinical trial evidence such as the TIGRIS and EUPHRATES trials. The company is ISO 13485:2016 certified with corporate stock of €333,600.

Name

Estor

Legal name

Estor S.p.A.

Website

https://www.estor.it/

Company type

Private

Founded year

1999

Operating status

Operating

Short description

Estor S.p.A. is an Italian B2B medical device distributor supplying extracorporeal blood purification, organ support, and dialysis devices from Toray and Spectral Medical to hospitals, intensive care units, and nephrology departments across Italy.

Ownership category

akta.pro rank

Headquarters

HQ city

Pero

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales, Personnel, Operations, Technology or R&D

Revenue model

1. Medical Device Distribution: Estor distributes proprietary extracorporeal blood purification, organ support, and dialysis medical devices to hospitals, intensive care units, and nephrology departments in Italy. Revenue is generated through product sales of distributed devices including hemoperfusion systems, CRRT machines, dialysis membranes, and diagnostic assays. The company acts as a distributor for Toray Medical and Spectral Medical products in its served markets.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Estor S.p.A. is an Italian medical device company that distributes and supplies extracorporeal blood purification, organ support, and dialysis medical devices manufactured primarily by Toray Medical (Japan) and Spectral Medical (Canada). The company serves Italian hospitals, intensive care units, and nephrology departments with hemoperfusion systems, CRRT machines, dialysis membranes, and diagnostic assays used in the treatment of endotoxic septic shock, acute kidney injury, chronic kidney disease, acute respiratory failure, mitral valve stenosis, and brain injury. Estor operates as a clinical-evidence-led specialty distributor with its own branded equipment (EstorFlow, INTENSA, EstorClean Plus) and supports customers through scientific congress participation and clinical education.

Product overview

Estor is a medical device company offering a comprehensive portfolio of extracorporeal blood purification and organ support therapies for critical care. The core offerings include TORAYMYXIN® (Polymyxin B hemoperfusion for endotoxic septic shock) paired with EAA™ (FDA-approved endotoxin diagnostic assay) for precision therapy selection. The product line spans hemoperfusion systems (EstorFlow®), multimodal extracorporeal organ support machines (INTENSA®), and specialized membranes (HEMOFEEL™ PMMA membrane, ProLUNG® for CO2 removal). For chronic kidney disease, Estor distributes TORAY's complete dialysis membrane portfolio including PMMA FILTRYZER (B3-A, BG-U, BK-F variants), TORAYLIGHT NS-S, HYDROLINK NV-U, and TORAYSULFONE TS-UL dialyzers. Additional offerings include the Inoue® Catheter for mitral valve procedures, dialysis water filtration (EstorClean Plus®), and nutritional monitoring/ supplementation products (EFG Plus®, RenaCare). The company operates as a distributor for TORAY Medical products in Italy while maintaining its own product development capabilities.

Differentiator

Problem solved

Functional benefit

Brands

• EstorFlow®: Hemoperfusion system for healthcare professionals, supporting Toraymyxin® and ProLUNG® treatments.
• INTENSA®
• EstorClean Plus®

Products and services

• TORAYMYXIN Polymyxin B hemoperfusion therapy for treatment of patients with endotoxic septic shock unresponsive to conventional treatment. Available in PMX-20R (adult body volume) and PMX-05R (reduced volume) versions. Removes up to 90% of circulating endotoxin after two hemoperfusion sessions.
• EAA (Endotoxin Activity Assay) Rapid diagnostic assay to detect endotoxin activity in human whole blood. FDA-approved and CE-marked, performed in less than 30 minutes. Used to guide Polymyxin B hemoperfusion therapy and patient selection for clinical trials.
• EstorFlow Hemoperfusion system for healthcare professionals with dedicated software guiding procedure steps including circuit rinsing/priming, anticoagulant calculation, pressure monitoring, and automatic blood flow adjustment. Operates with Toraymyxin, ProLUNG, and general HP modalities.
• INTENSA Multimodal system for Extracorporeal Organ Support (ECOS) in critically ill patients. Supports CRRT modalities (CVVH, CVVHD, CVVHDF, SCUF), CRRT-EAD with Sequential Adsorption Clamp (SAC), SETS (TORAYMYXIN + HEMOFEEL), hemoperfusion, LF-ECCO2R, and regional anticoagulation with citrate/calcium.
• ProLUNG Reference system for Low Flow Extracorporeal CO2 Removal (LF-ECCO2R) providing high CO2 removal (VCO2 > 100 ml/min) with real-time monitoring via ProLUNG Meter. Uses a hemoperfusion circuit with 1.8 m² polymethylpentene membrane coated with phosphorylcholine for applications including moderate ARDS, COPD exacerbations, lung transplantation, tissue lesions, and COVID-19.
• HEMOFEEL Polymethylmethacrylate (PMMA) membrane for continuous renal support. Provides hemo- and biocompatibility, immunoprotection, immunomodulation, and innovative renal support with adsorption capability for removal of medium and high molecular weight molecules including cytokines and inflammatory mediators.
• TORAY PMMA FILTRYZER Series of hemodialysis membranes made from polymethylmethacrylate (PMMA) for chronic kidney disease patients. Includes B3-A (standard biocompatibility), BG-U (uremic pruritus, inflammatory mediator removal, A-HDF), and BK-F (large pore size ~100Å for PBUT, sFLC, cardiovascular risk). Unique adsorption characteristics alongside diffusion and convection filtration enabling personalized dialysis.
• Inoue Balloon Catheter Balloon catheter for Percutaneous Transvenous Mitral Commissurotomy (PTMC) for patients with mitral valve stenosis. Features volume-controlled hourglass balloon shape and rapid 5-second inflation/deflation cycle. Particularly suitable for elderly patients, pregnant patients, and those with comorbidities unsuitable for major surgery.
• TORAY HYDROLINK NV-U Revolutionary dialysis membrane with antithrombogenicity allowing dramatic reduction of anticoagulant use and potential improvement of intradialytic hypotension for chronic hemodialysis patients.
• TORAY TORAYSULFONE TS-UL High-flux polysulfone dialyzer designed for maximizing internal diffusion and convective forces. Pioneer in Internal Hemodiafiltration (iHDF) with excellent water permeability for hemodialysis and HDF applications.
• TORAY TORAYLIGHT NS-S High-flux dialyzer using modified Polysulfone membrane with moist technology and cross-linking technology for PVP control. Features 60% weight reduction compared to wet-type dialyzers for chronic hemodialysis.
• EstorClean Plus Dialysis water treatment filter for accurate ultrafiltration of reverse osmosis water, removing bacterial DNA fragments to achieve ultrapure water standards for dialysis applications.
• EFG Plus Advanced BIVA (Bioelectrical Impedance Vector Analysis) technology platform for hydration and nutrition monitoring in nephropathic patients. Features touch-screen design with Hydrogram and Nutrigram scales.
• RenaCare Nutritional Supplements Nutritional supplements (Renapro, Renergy, Renamil) designed for nephropathic patients with minimum potassium and phosphorus content for patients requiring hemodialysis.

Quantifiable outcome

• 28-day mortality absolute risk reduction of 6.4% (posterior probability of benefit 95.3%) and 90-day mortality reduction of 17.4% (posterior probability of benefit 99.4%) in endotoxic septic shock patients treated with Polymyxin B Hemoadsorption in the TIGRIS trial.
• +4 more outcomes

Named customers4 records

Segments6 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Toray Medical Co., Ltd. (Japan)coreTechnology or IntegrationEstor distributes Toray Medical's portfolio of extracorporeal blood purification and dialysis products in Italy, including Toraymyxin® Polymyxin B hemoperfusion, PMMA FILTRYZER membranes, HEMOFEEL™ membranes, INTENSA® ECOS system, EstorFlow® system, ProLUNG® LF-ECCO2R, and related dialysis equipment (TR-8000 YUGA, TQS-88). Toray is a Japanese worldwide leader in nanotechnologies, chemistry, and advanced membrane development and the only manufacturer of PMMA dialysis membranes.
• Spectral Medical Inc. (Canada)coreTechnology or IntegrationEstor distributes Spectral Medical's EAA™ (Endotoxin Activity Assay) in Italy — the only FDA-approved and CE-marked rapid diagnostic assay to detect endotoxin activity in human whole blood. Spectral collaborated with Toray and Estor on the EUPHRATES and TIGRIS clinical trials for patient selection using the EAA™ diagnostic.
• ConfindustriaminorOthersEstor S.p.A. is a member of Confindustria (Italian employers' confederation), specifically associated with Confindustria Dispositivi Medici (medical devices sector), demonstrating adherence to Italian industrial standards and representation in the medical devices sector.
• DirexminorChannel Partner/ Reseller/ DistributorEstor partners with Direx at ISICIP (International Symposium on Infections in the Critically Ill), with Direx representing Estor at this congress event.
• RenaCare (Germany)minorChannel Partner/ Reseller/ DistributorEstor distributes RenaCare nutritional supplements (Renapro®, Renergy®, Renamil®) designed for nephropathic patients with minimal potassium and phosphorus content, designed for patients requiring hemodialysis.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Fresenius Medical Care: Global leader in dialysis products and services, including hemodialysis machines, dialyzers, and CRRT systems. Directly comparable to Estor as a supplier of dialysis and blood purification therapies to Italian hospitals, but at vastly larger scale and with proprietary manufacturing.
• Baxter International: Diversified medical device company with a strong CRRT and acute dialysis portfolio (e.g., PrisMax, HF440 set). Competes with Estor/INTENSA in Italian ICUs and overlaps with Estor's AKI and CRRT value proposition.
• B. Braun: Major European medical device manufacturer with a dedicated dialysis and apheresis business (Diacap, OMNI). Competitor to Estor's dialysis membrane and CRRT offering in Italian nephrology and ICU settings.
• Medtronic: Global medical device incumbent with renal care solutions (e.g., Bellco legacy CRRT). Overlaps with Estor in Italian critical care and acute dialysis procurement at hospitals.

Direct peers

• Nikkiso: Japanese manufacturer of CRRT and dialysis machines with European distribution. Closely comparable to Toray/Estor's combined CRRT and hemoperfusion positioning, particularly relevant for Italian ICU procurement.
• Asahi Kasei Medical: Manufacturer of hollow-fiber dialysis membranes (e.g., APS series) and therapeutic apheresis products. Directly competes with Toray's PMMA FILTRYZER portfolio that Estor distributes, especially in chronic dialysis tenders.
• Spectral Medical: Canadian diagnostics company whose EAA™ endotoxin assay is distributed by Estor in Italy. Spectral also develops PMX therapy commercialization pathways, creating overlap and a parallel commercialization channel risk.

Others

• Toray Medical: Japanese manufacturer and Estor's core supplier. Although Toray's products underpin Estor's portfolio, Toray's own direct presence in some European markets makes it a partial peer and a strategic dependency risk.

Emerging players

• CytoSorbents: US-listed company commercializing CytoSorb blood purification for sepsis and cytokine removal. A direct functional competitor to Toraymyxin®/EAA™ in the ICU sepsis niche, with growing European presence.
• Jafron Biomedical: Chinese manufacturer of hemoperfusion cartridges (HA series) competing with Toraymyxin® in sepsis and toxin removal. An emerging low-cost alternative that could pressure Estor's pricing in Italian tenders.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Estor